EGFR and breast carcinoma: Estradiol is known to rapidly activate many signaling molecules, including insulin-like growth factor 1 receptor (IGF-IR), epidermal growth factor receptor (EGFR), and mitogen-activated protein kinase (MAPK) in breast cancer cells.